Legend Biotech Corporation Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Legend Biotech Corporation (LEGN) holds an ST Score of 54.6 out of 100 (B-), with its strongest factor being Profitability (A+) and its weakest Financial Strength (D). Analysts rate LEGN Buy across 20 ratings with a $56.14 average price target (+2.2% vs the current $17.61).
- Strongest
- ProfitabilityA+
- Weakest
- Financial StrengthD
All factor grades
- ProfitabilityA+
- GrowthA-
- ForecastB+
- ValuationB
- MomentumD+
- Financial StrengthD
- Piotroski3/9
Contact
LEGN stock: frequently asked questions
What is LEGN's ST Score?
Legend Biotech Corporation (LEGN) has an ST Score of 54.6 out of 100, an overall grade of B-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is LEGN a buy, sell, or hold?
Wall Street's consensus rating on LEGN is Buy based on 20 analyst ratings. Our own ST Score grades it B- (54.6/100). This is data, not investment advice — always do your own research.
What is LEGN's valuation grade?
Legend Biotech Corporation (LEGN) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is LEGN's growth grade?
Legend Biotech Corporation (LEGN) earns a growth grade of A-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is LEGN's profitability grade?
Legend Biotech Corporation (LEGN) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is LEGN's financial strength grade?
Legend Biotech Corporation (LEGN) earns a financial strength grade of D, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for LEGN?
The average analyst price target for Legend Biotech Corporation (LEGN) is $56.14 from 20 analysts, which is +2.2% versus the recent price of $17.61.
What is LEGN's Piotroski score?
Legend Biotech Corporation (LEGN) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.